Covaryx Pregnancy Warnings
There appears to be little or no increased risk of birth defects in children born to women who have combination oral contraceptives (estrogens and progestins) inadvertently during early pregnancy. Methyltestosterone should not be used during pregnancy because of the possibility of masculinization of the female fetus. There are no controlled data in human pregnancy.
US FDA pregnancy category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Use is contraindicated
US FDA pregnancy category: Category X
Comments:
-There is no indication for use in pregnancy; if a patient becomes pregnant while taking this drug, she should be apprised of the potential risks to the fetus.
See references
Covaryx Breastfeeding Warnings
Use is contraindicated
Excreted into human milk: Yes (estrogen); Unknown (methyltestosterone)
Excreted into animal milk: Data not available
Comments:
-Androgens are contraindicated in nursing mothers because of the possibility of masculinization of the nursing infant.
-Estrogen administration to nursing mothers has been shown to decrease the quantity and quality of breastmilk.
See references
